Results 31 to 40 of about 112,859 (310)
The diagnosis of non‐alcoholic fatty liver disease [PDF]
Alimentary Pharmacology & Therapeutics, 2011 no ...
Wlazlo, Nick +4 more
openaire +6 more sources
Statins and non‐alcoholic fatty liver disease [PDF]
Liver International, 2019 Dear Editor, In April 9 issue, van den Berg et al1 report interesting results on the indication for lipid‐lowering treatment in a large cohort with suspected non‐alcoholic fatty liver disease (NAFLD) within the population‐based Lifelines Cohort Study.
Angelico F +3 more
openaire +2 more sources
An Exploration of the Treatment of Non-Alcoholic Fatty Liver Disease Based on Dietary Factors [PDF]
BIO Web of ConferencesNon-alcoholic fatty liver disease is a clinical pathological syndrome characterized by diffuse hepatocellular macrovesicular steatosis caused by other liver-damaging factors except for alcohol.
Yang Wanzhou
doaj +1 more source
Macrophage Activation in Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) Correlates with Hepatic Progenitor Cell Response via Wnt3a Pathway. [PDF]
PLoS ONE, 2016 Non-alcoholic fatty liver disease is one of the most important causes of liver-related morbidity in children. In non-alcoholic fatty liver disease, the activation of liver resident macrophage pool is a central event in the progression of liver injury ...
Guido Carpino +10 more
doaj +1 more source
Non-alcoholic fatty liver disease and liver secretome
Archives of Pharmacal Research, 2022 Metabolism of carbohydrates and lipids and protein degradation occurs in the liver and contributes to the body's homeostasis by secreting a variety of mediators. Any imbalance in this homeostasis due to excess fat consumption and the pathologic events accompanying lipotoxicity, autophagy dysregulation, endoplasmic reticulum stress, and insulin ...
Muhammad Sohaib Khan +2 more
openaire +2 more sources
Platelets in Non-alcoholic Fatty Liver Disease [PDF]
Frontiers in Pharmacology, 2022 Non alcoholic steatohepatitis (NASH) is the inflammatory reaction of the liver to excessive accumulation of lipids in the hepatocytes. NASH can progress to cirrhosis and hepatocellular carcinoma (HCC). Fatty liver is the hepatic manifestation of metabolic syndrome.
Andrea Dalbeni +6 more
openaire +3 more sources
Therapeutic Advances in Gastroenterology, 2021 Introduction: The optimal approach to screening and risk stratification for non-alcoholic fatty liver disease is challenging given disease burden and variable progression. The aim of this study was to assess primary care physician and referring physician
Naba Saeed +6 more
doaj +1 more source
Frontiers in Molecular Biosciences, 2022 Background and Objective: Although growing evidence indicates that non-alcoholic fatty liver disease is related to diabetic retinopathy (DR), research results significantly vary.
Guo-heng Zhang +7 more
doaj +1 more source
Heterogeneity of non‐alcoholic fatty liver disease [PDF]
Liver International, 2015 See Article on Page ...
Yki‐Järvinen, Hannele +1 more
openaire +2 more sources
Pathology of non-alcoholic fatty liver disease
Pathologica, 2021 Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of different conditions which are characterized by hepatic steatosis in the absence of secondary causes. It is currently the most common chronic liver disease worldwide, and its estimated prevalence is about 1.5-6.5%.
Cataldo, Ivana +7 more
openaire +4 more sources